repotrectinib
(REE-poh-TREK-tih-nib)
A drug used to treat adults with non-small cell lung cancer that has spread and has an abnormal ROS1 gene and adults and children aged 12 years and older with certain types of solid tumors that have an NTRK gene fusion. It is also being studied in the treatment of other types of cancer. Repotrectinib blocks certain proteins involved in cell signaling and cell growth. Blocking these proteins may help keep cancer cells from growing. Repotrectinib is a type of kinase inhibitor. Also called Augtyro.